Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2017

Apr 27, 2017

31046_dirs_2017-04-27_7a66dd2a-db8e-478a-a2ff-497f565fdc59.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-04-20

Reporting Person: Complete Pharma Holdings II, LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6683598 Direct